Axxion S.A.’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-100,000
Closed -$416K – 590
2026
Q2
$416K Buy
+100,000
New +$380K 0.03% 246

Other funds holding IOVA

Axxion S.A.'s IOVA Position: Q3 2026 in Review

Axxion S.A. sold out of Iovance Biotherapeutics (IOVA) in Q3 2026, closing a stake of 100,000 shares — an estimated $416K sold.

Axxion S.A. first reported a position in IOVA in Q2 2026 and held it in 1 quarter. The position peaked at $416K in Q2 2026. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Axxion S.A. reported no remaining Iovance Biotherapeutics position as of Q3 2026 after selling out during the quarter.
  • Axxion S.A. sold 100,000 Iovance Biotherapeutics shares in Q3 2026, an estimated $416K.
  • Axxion S.A. first reported a position in Iovance Biotherapeutics in Q2 2026 and held it in 1 quarter.
  • Axxion S.A.'s Iovance Biotherapeutics position peaked at $416K in Q2 2026.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.